Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessResearch

Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content

Do Kyung Lee1 email, Seok Jang1 email, Eun Hye Baek1 email, Mi Jin Kim1 email, Kyung Soon Lee2 email, Hea Soon Shin3 email, Myung Jun Chung4 email, Jin Eung Kim4 email, Kang Oh Lee5 email and Nam Joo Ha1 email

Department of Pharmacy, Sahmyook University, Seoul 139-742, Republic of Korea

Department of Nursing, Sahmyook University, Seoul 139-742, Republic of Korea

College of Pharmacy, Duksung Women's University, Seoul 132-714, Republic of Korea

Cellbiotech Co Ltd, Seoul 157-030, Republic of Korea

Department of Life Science, Sahmyook University, Seoul 139-742, Republic of Korea

author email corresponding author email

Lipids in Health and Disease 2009, 8:21doi:10.1186/1476-511X-8-21

Published: 11 June 2009

Abstract

Background

Lactic acid bacteria (LAB) are beneficial probiotic organisms that contribute to improved nutrition, microbial balance, and immuno-enhancement of the intestinal tract, as well as lower cholesterol. Although present in many foods, most trials have been in spreads or dairy products. Here we tested whether Bifidobacteria isolates could lower cholesterol, inhibit harmful enzyme activities, and control fecal water content.

Methods

In vitro culture experiments were performed to evaluate the ability of Bifidobacterium spp. isolated from healthy Koreans (20~30 years old) to reduce cholesterol-levels in MRS broth containing polyoxyethanylcholesterol sebacate. Animal experiments were performed to investigate the effects on lowering cholesterol, inhibiting harmful enzyme activities, and controlling fecal water content. For animal studies, 0.2 ml of the selected strain cultures (108~109 CFU/ml) were orally administered to SD rats (fed a high-cholesterol diet) every day for 2 weeks.

Results

B. longum SPM1207 reduced serum total cholesterol and LDL levels significantly (p < 0.05), and slightly increased serum HDL. B. longum SPM1207 also increased fecal LAB levels and fecal water content, and reduced body weight and harmful intestinal enzyme activities.

Conclusion

Daily consumption of B. longum SPM1207 can help in managing mild to moderate hypercholesterolemia, with potential to improve human health by helping to prevent colon cancer and constipation.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.